BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29254643)

  • 1. Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII).
    Koltun DO; Parkhill EQ; Kalla R; Perry TD; Elzein E; Li X; Simonovich SP; Ziebenhaus C; Hansen TR; Marchand B; Hung WK; Lagpacan L; Hung M; Aoyama RG; Murray BP; Perry JK; Somoza JR; Villaseñor AG; Pagratis N; Zablocki JA
    Bioorg Med Chem Lett; 2018 Feb; 28(3):541-546. PubMed ID: 29254643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure based optimization of 2-(4-phenoxybenzoyl)-5-hydroxyindole as a novel CaMKII inhibitor.
    Komiya M; Asano S; Koike N; Koga E; Igarashi J; Nakatani S; Isobe Y
    Bioorg Med Chem; 2012 Dec; 20(23):6840-7. PubMed ID: 23088910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and activity relationship of 2-(substituted benzoyl)-hydroxyindoles as novel CaMKII inhibitors.
    Komiya M; Asano S; Koike N; Koga E; Igarashi J; Nakatani S; Isobe Y
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1456-8. PubMed ID: 21292482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel benzo-fused heteroaryl derivatives as Ca²⁺/calmodulin-dependent protein kinase II inhibitors.
    Komiya M; Asano S; Koike N; Koga E; Igarashi J; Nakatani S; Isobe Y
    Chem Pharm Bull (Tokyo); 2013; 61(10):1094-7. PubMed ID: 24088703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin is an inhibitor of calcium/calmodulin dependent protein kinase II.
    Mayadevi M; Sherin DR; Keerthi VS; Rajasekharan KN; Omkumar RV
    Bioorg Med Chem; 2012 Oct; 20(20):6040-7. PubMed ID: 22989913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors.
    Asano S; Komiya M; Koike N; Koga E; Nakatani S; Isobe Y
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6696-8. PubMed ID: 20875738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy.
    Beauverger P; Ozoux ML; Bégis G; Glénat V; Briand V; Philippo MC; Daveu C; Tavares G; Roy S; Corbier A; Briand P; Dorchies O; Bauchet AL; Nicolai E; Duclos O; Tamarelle D; Pruniaux MP; Muslin AJ; Janiak P
    Cardiovasc Res; 2020 Feb; 116(2):329-338. PubMed ID: 31038167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II-induced oxidative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase II and promotes a death pathway conserved across different species.
    Palomeque J; Rueda OV; Sapia L; Valverde CA; Salas M; Petroff MV; Mattiazzi A
    Circ Res; 2009 Dec; 105(12):1204-12. PubMed ID: 19850941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a selective CaMKII peptide inhibitor.
    Gomez-Monterrey I; Sala M; Rusciano MR; Monaco S; Maione AS; Iaccarino G; Tortorella P; D'Ursi AM; Scrima M; Carotenuto A; De Rosa G; Bertamino A; Vernieri E; Grieco P; Novellino E; Illario M; Campiglia P
    Eur J Med Chem; 2013 Apr; 62():425-34. PubMed ID: 23395965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocopherol suppresses 24(S)-hydroxycholesterol-induced cell death via inhibition of CaMKII phosphorylation.
    Kimura Y; Asa M; Urano Y; Saito Y; Nishikawa K; Noguchi N
    Biochimie; 2018 Oct; 153():203-209. PubMed ID: 30244813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors.
    Pastor RM; Burch JD; Magnuson S; Ortwine DF; Chen Y; De La Torre K; Ding X; Eigenbrot C; Johnson A; Liimatta M; Liu Y; Shia S; Wang X; Wu LC; Pei Z
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2448-52. PubMed ID: 24767842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias.
    Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A purine analog kinase inhibitor, calcium/calmodulin-dependent protein kinase II inhibitor 59, reveals a role for calcium/calmodulin-dependent protein kinase II in insulin-stimulated glucose transport.
    Konstantopoulos N; Marcuccio S; Kyi S; Stoichevska V; Castelli LA; Ward CW; Macaulay SL
    Endocrinology; 2007 Jan; 148(1):374-85. PubMed ID: 17008397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of calcium/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats.
    Daniels LJ; Wallace RS; Nicholson OM; Wilson GA; McDonald FJ; Jones PP; Baldi JC; Lamberts RR; Erickson JR
    Cardiovasc Diabetol; 2018 Jun; 17(1):89. PubMed ID: 29903013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elaborate ligand-based modeling and subsequent synthetic exploration unveil new nanomolar Ca2+/calmodulin-dependent protein kinase II inhibitory leads.
    Shahin R; Taha MO
    Bioorg Med Chem; 2012 Jan; 20(1):377-400. PubMed ID: 22112539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit.
    Qiu H; Liu-Bujalski L; Caldwell RD; Follis AV; Gardberg A; Goutopoulos A; Grenningloh R; Head J; Johnson T; Jones R; Mochalkin I; Morandi F; Neagu C; Sherer B
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2939-2944. PubMed ID: 30122225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a novel series of 4-quinolone JNK inhibitors.
    Gong L; Tan YC; Boice G; Abbot S; McCaleb K; Iyer P; Zuo F; Dal Porto J; Wong B; Jin S; Chang A; Tran P; Hsieh G; Niu L; Shao A; Reuter D; Lukacs CM; Ursula Kammlott R; Kuglstatter A; Goldstein D
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7381-7. PubMed ID: 23142618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CaMKII and at least two unidentified kinases phosphorylate regulatory light chain in non-contracting cardiomyocytes.
    Eikemo H; Moltzau LR; Nguyen CHT; Levy FO; Skomedal T; Osnes JB
    Biochem Biophys Res Commun; 2016 Aug; 477(1):14-19. PubMed ID: 27237977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potent and selective thienopyrimidine inhibitors of Aurora kinases.
    McClellan WJ; Dai Y; Abad-Zapatero C; Albert DH; Bouska JJ; Glaser KB; Magoc TJ; Marcotte PA; Osterling DJ; Stewart KD; Davidsen SK; Michaelides MR
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5620-4. PubMed ID: 21778056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha1-adrenoceptor stimulation potentiates L-type Ca2+ current through Ca2+/calmodulin-dependent PK II (CaMKII) activation in rat ventricular myocytes.
    O-Uchi J; Komukai K; Kusakari Y; Obata T; Hongo K; Sasaki H; Kurihara S
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9400-5. PubMed ID: 15964981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.